Dr. Lucy Michelle Safi, DO

Dr. Safi practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Safi's NPI, 1164659603, was assigned on June 11, 2009. Dr. Safi graduated from Philadelphia College of Osteopathic Medicine in 2009. Dr. Safi holds New York license 320976.

Dr. Safi's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Safi also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Safi's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Safi is also affiliated with Mount Sinai West. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Safi to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safi practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Safi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Safi's licenses on file in 2 states: New York and New Jersey.

CMS data shows 1,604 Medicare services from Dr. Safi across 10 procedure codes in 2024, for 945 Medicare patients. Medicare paid $98,705 for them.

CMS counts 945 Medicare patients who saw Dr. Safi in 2024. The largest group is 75 to 84, with 351 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Safi's median patient age at 67, with 48% women.

In 2024, Dr. Safi wrote 40 Medicare Part D claims for 22 patients. 90% of them were for generic drugs. They cover 23 drugs, with $222,996 in total drug cost. In 2022, CMS named 1,828 claims across 31 drugs.

Dr. Safi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Safi, published from 2016 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Aortic Valve, Aortic Valve Stenosis and Heart Valve Prosthesis. Dr. Safi has published most often in CASE (Phila). Dr. Safi's most frequent co-authors are Gilbert Hin Lung Tang, MD, Stamatios Lerakis, MD and Annapoorna S. Kini, MD.

CMS Open Payments shows 525 general payments to Dr. Safi from 24 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 34% of the total. Abbott Laboratories paid the most, $72,062. It also lists 1 research payment totaling $92 in 2024.

Dr. Safi graduated from Philadelphia College of Osteopathic Medicine in 2009.